Carregant...
A Bayesian Sequential Design for Clinical Trials with Time-to-Event Outcomes
There is increasing interest in Bayesian group sequential design because of its potential to improve efficiency in clinical trials, to shorten drug development time, and to enhance statistical inference precision without undermining the clinical trial’s integrity or validity. We propose a Bayesian s...
Guardat en:
| Publicat a: | Stat Biopharm Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100880/ https://ncbi.nlm.nih.gov/pubmed/32226580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2019.1629996 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|